ozagrel   Click here for help

GtoPdb Ligand ID: 9866

Synonyms: Cataclot® | KCT-0809 | OKY-046 | Pulmoza®
Approved drug Immunopharmacology Ligand
ozagrel is an approved drug (China and Japan only)
Compound class: Synthetic organic
Comment: Ozagrel is a thromboxane A synthetase (CYP5A1; TBXAS1) inhibitor that has anti-inflammatory action [3]. Note that some of the bioactivity data for ozagrel relate to use of ozagrel sodium or ozagrel hydrochloride.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 4
Topological polar surface area 55.12
Molecular weight 228.09
XLogP 1.86
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)C=Cc1ccc(cc1)Cn1ccnc1
Isomeric SMILES OC(=O)/C=C/c1ccc(cc1)Cn1ccnc1
InChI InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+
InChI Key SHZKQBHERIJWAO-AATRIKPKSA-N
Immunopharmacology Comments
The anti-asthmatic activity of ozagrel founded the search for novel thromboxane synthetase inhibitors as drugs for bronchial inflammation. Inhibition of thromboxane synthetase blocks generation of thromboxane inflammatory mediators (e.g. TXA2 and TXB2). This action also brings about bronchodilatory effects [3].